Healthcare Docket: The Telehealth Boom is Inciting Action by Lawmakers and Fraudsters Alike

Ever since the Covid-19 pandemic pushed telehealth to the forefront of American healthcare modalities, the genie has emerged from the lamp to quite a mixed crowd of cheerleaders and cheaters. On March 15, telehealth’s now proven benefits spurred four Republican and three Democratic United States House of Representative members to introduce legislation to extend telehealth flexibilities for…

Read More

Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1) – Life Sciences, Biotechnology & Nanotechnology

To print this article, all you need is to be registered or login on Mondaq.com. What You Need to Know Key takeaway#1 Broad Interpretation of Safe Harbor: The Federal Circuit’s decision underscores a broad interpretation of the safe harbor provision. Companies can be reassured that activities potentially perceived as an infringing importation or use…

Read More

Morning Docket: 04.03.24

* Complaint claims George W. Bush appointed Judge Reggie Walton tainted jury pools when he participated in a televised interview saying Donald Trump’s false claims attacking judges and their families have led to death threats. You’d think the attacks from the guy who used to be president would be doing more to taint jury pools……

Read More

Ongoing Capital Challenges Portend Continued Portfolio Company Litigation Risk In 2024 – Corporate and Company Law

To print this article, all you need is to be registered or login on Mondaq.com. Economic headwinds and the interest rate environment that developed over the course of 2023 increased financial stress on portfolio companies and portend heightened litigation risk in 2024 for portfolio companies and their private fund sponsors. Specifically, interest rate increases…

Read More

Interpretable Algorithms As A Potential Solution To CFPB’s Guidance On AI-Driven Credit Denials – Financial Services

03 April 2024 Goodwin Procter LLP To print this article, all you need is to be registered or login on Mondaq.com. In September 2023, the Consumer Financial Protection Bureau (CFPB) issued guidance on the use of artificial intelligence in issuing credit denials, a prevalent practice among lenders. The CFPB explained that when denying…

Read More

A Changing Regulatory And Reimbursement Landscape For Weight-Loss Drugs – Healthcare

Prescriptions for a new class of drugs to treat obesity surged exponentially in 2023. Originally approved for treatment of type 2 diabetes, glucagon-like peptide-1 receptor agonist drugs (GLP-1s) such as Wegovy, Zepbound, Ozempic, and Mounjaro have been a popular choice for obesity treatment and general weight loss despite the drugs’ significant price tags and limited…

Read More

One Day, Many Complaints – Above the Law

In last week’s column, I expressed my interest in doing a review of all patent complaints filed on a particular day. For what purpose? I believe it is important for active litigators and counselors to maintain “a sense of what types of cases are being filed right now,” so that they can offer timely and…

Read More